Alkynes

Results: 297



#Item
141Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee December 9, 2011  Scott Monroe, MD

Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee December 9, 2011 Scott Monroe, MD

Add to Reading List

Source URL: www.fda.gov

Language: English
142Overactive bladder drugs compared - Consumer Reports Health

Overactive bladder drugs compared - Consumer Reports Health

Add to Reading List

Source URL: consumerhealthchoices.org

Language: English - Date: 2013-07-06 14:29:13
143NDA[removed]DITROPAN (oxybutynin chloride) Tablets (Final Draft submitted[removed])  NDA[removed]DITROPAN (oxybutynin chloride) Syrup (Final Draft submitted[removed]DITROPAN® (oxybutynin chloride) Tablets and Syru

NDA[removed]DITROPAN (oxybutynin chloride) Tablets (Final Draft submitted[removed])  NDA[removed]DITROPAN (oxybutynin chloride) Syrup (Final Draft submitted[removed]DITROPAN® (oxybutynin chloride) Tablets and Syru

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-04-09 09:20:37
144NDA[removed]S-013 Page 3 DITROPAN XL (oxybutynin chloride) Extended Release Tablets

NDA[removed]S-013 Page 3 DITROPAN XL (oxybutynin chloride) Extended Release Tablets

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-04-09 09:20:38
145Pediatric Focused Safety Review: Beyaz (ethinyl estradiol, drospirenone, levomefolate calcium) Pediatric Advisory Committee Meeting September 11, 2012

Pediatric Focused Safety Review: Beyaz (ethinyl estradiol, drospirenone, levomefolate calcium) Pediatric Advisory Committee Meeting September 11, 2012

Add to Reading List

Source URL: www.fda.gov

Language: English
146FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Co

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Co

Add to Reading List

Source URL: www.fda.gov

Language: English
147Benchmark Positions, by Occupational Group AR Group BM Title K&S AR3a

Benchmark Positions, by Occupational Group AR Group BM Title K&S AR3a

Add to Reading List

Source URL: www.psc.gov.yk.ca

Language: English - Date: 2014-09-12 18:38:23
148Microsoft Word[removed]4295b_01_02_Cover Memo_Murphy.doc

Microsoft Word[removed]4295b_01_02_Cover Memo_Murphy.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-04-09 09:20:36
149M I F E P R E X™ (Mifepristone) Tablets, 200 mg PRESCRIBER’S AGREEMENT We are pleased that you wish to become a provider of Mifeprex* (Mifepristone) Tablets, 200 mg, which is indicated for the medical termination of

M I F E P R E X™ (Mifepristone) Tablets, 200 mg PRESCRIBER’S AGREEMENT We are pleased that you wish to become a provider of Mifeprex* (Mifepristone) Tablets, 200 mg, which is indicated for the medical termination of

Add to Reading List

Source URL: www.fda.gov

Language: English
150M I F E P R E X™ (Mifepristone) Tablets, 200 mg PRESCRIBER’S AGREEMENT We are pleased that you wish to become a provider of Mifeprex* (Mifepristone) Tablets, 200 mg, which is indicated for the medical termination of

M I F E P R E X™ (Mifepristone) Tablets, 200 mg PRESCRIBER’S AGREEMENT We are pleased that you wish to become a provider of Mifeprex* (Mifepristone) Tablets, 200 mg, which is indicated for the medical termination of

Add to Reading List

Source URL: www.fda.gov

Language: English